{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:44:11Z","timestamp":1792658651848,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"vor","delay-in-days":1018,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ihj.2013.06.026","type":"journal-article","created":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T20:15:39Z","timestamp":1374351339000},"page":"388-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study)"],"prefix":"10.1016","volume":"65","author":[{"given":"Jacek","family":"Legutko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zasada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz L.","family":"Ka\u0142u\u017ca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Heba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Rzeszutko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Jakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Dragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Klecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Giszterowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Dobrowolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Partyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2013.06.026_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMp068305","article-title":"Unanswered questions \u2013 drug-eluting stents and the risk of late thrombosis","volume":"356","author":"Maisel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2013.06.026_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A\u00a0pooled analysis of data comparing sirolimus-eluting stents with bare metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2013.06.026_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus and paclitaxel-eluting stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2013.06.026_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2013.06.026_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ccd.20692","article-title":"Very late thrombosis after drug-eluting stents","volume":"68","author":"Feres","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2013.06.026_bib6","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2013.06.026_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2013.06.026_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2011.06.027","article-title":"ISAR-TEST 4 Investigators. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial","volume":"58","author":"Byrne","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2013.06.026_bib9","first-page":"426","article-title":"Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial","volume":"2","author":"Chevalier","year":"2007","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ihj.2013.06.026_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4244\/EIJV6I8A162","article-title":"The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer","volume":"6","author":"Garg","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ihj.2013.06.026_bib11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/CIRCINTERVENTIONS.109.891192","article-title":"New drug-eluting stents an overview on biodegradable and polymer-free next-generation stent systems","volume":"3","author":"Abizaid","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2013.06.026_bib12","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","article-title":"ACC Clinical Expert Consensus Document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS)","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2013.06.026_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCINTERVENTIONS.109.916502","article-title":"Late and very late drug-eluting stent malapposition, serial 2-Year quantitative IVUS analysis","volume":"3","author":"Kang","year":"2010","journal-title":"Circ Cardiovasc Interventions"},{"key":"10.1016\/j.ihj.2013.06.026_bib14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2013.06.026_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2010.10.046","article-title":"The relationship between late lumen loss and restenosis among various drug-eluting stents: a systematic review and meta-regression analysis of randomized clinical trials","volume":"214","author":"Brener","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ihj.2013.06.026_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.CIR.0000112572.57794.22","article-title":"Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis","volume":"109","author":"Holmes","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2013.06.026_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.105.575977","article-title":"Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss","volume":"113","author":"Mehilli","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2013.06.026_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/eurheartj\/ehp044","article-title":"A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2013.06.026_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcin.2009.02.009","article-title":"1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial","volume":"2","author":"Costa","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2013.06.026_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCINTERVENTIONS.110.946939","article-title":"Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry","volume":"3","author":"Stolker","year":"2010","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001948321300206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001948321300206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T08:21:56Z","timestamp":1539505316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001948321300206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S001948321300206X"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2013.06.026","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study)","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2013.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Cardiological Society of India. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}